Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Innovation Council · Running

HEARTCORE Human-based Advanced Cardiac Safety Platform Integrating Multilayer Cardiac Organoids, Mesh Mea, and Ai-based Proarrhythmia Risk Assessment

Coordinator
Medizinische Hochschule Hannover, Germany
Runs
1 June 2026 to 31 May 2030
Status
Running
EU funding
€3.0m
Total cost
€3.0m
Partners
5 organisations in 3 countries
Type
European Innovation Council
Grant agreement
101257413

What the project is doing

In the project's own words, from its summary on CORDIS.

Cardiac safety testing still relies on animal models or oversimplified in vitro assays that often fail to predict human outcomes, increasing the risk of drug-induced arrhythmias and delaying drug development. HEARTCORE will integrate physiologically relevant, human heart-forming organoids (HFOs) with a multilayer 3D mesh microelectrode array (mesh MEA) and laser-based optoporation, creating a groundbreaking new platform for cardiotoxicity testing and predicting drug responses in the short and long term.

A hiPSC-derived advanced HFO model will include a proper cardiac structure of endocardial, myocardial, and epicardial compartments, including sinoatrial node–like cells for replicating 3D electrophysiological properties of the heart. These organoids will be grown into a biocompatible double-layer mesh MEA to enable non-invasive, high-resolution field-potential recordings, spatial repolarization mapping, and 3D signal propagation analysis over time.

Optoporation will provide intracellular-like action potentials, while simultaneous calcium imaging and contraction monitoring will yield multiparametric datasets. To translate the data into actionable insights, we will develop a multi-scale in silico model, merging 3D spatial and temporal electrophysiological signatures with drug-specific effects to simulate proarrhythmic risk and deliver mechanistic predictions beyond current methods.

For elevated throughput screening, HEARTCORE will feature an optoporation-compatible high-electrode count MEA system with >1,000 channels in multiwell plates for 3D data acquisition and visualisation across the two mesh layers. Advanced software will create authentic 3D electrophysiological maps, overcoming the limitations of current 2D views. HEARTCORE aims to transform cardiac safety testing—improving risk detection, advancing patient-specific disease modeling, cutting drug development costs, and promoting human-relevant, animal-free in vitro models emulating native-like responses.

Topics

Who is involved

OrganisationCityCountryRole
Medizinische Hochschule HannoverHannoverGermanyCoordinator
Multi Channel Systems Mcs GmbHReutlingenGermanyParticipant
Naturwissenschaftliches Und Medizinisches Institut an Der Universitaet TuebingenReutlingenGermanyParticipant
Universitat Politecnica De ValenciaValenciaSpainParticipant
Foresee Biosystems SRLGenovaItalyParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI